Midaflur

Midaflur (INN; EXP 338) bụ 3-imidazoline siri ike nke nwere ihe na-eme ka ọkpụkpụ dị jụụ na ihe na-adọkpụ n'ime ụmụ mmadụ na ụdị anụmanụ na igbe akwụkwọ bụ ọgwụ ahụ n'ebe nile site n'aka ndị na ndị ọzọ na-enye nwa ara, na-egosipụta ọnụ dị elu na ogologo oge nke ọrụ.^[1] Ọ bụ ezie na a ka na-aghọtaghị ọgwụ ya nke ọma, midaflur yiri meprobamate na pentobarbital n'ihe gbasara mmetụta ndị a hụrụ mgbe ọ dị ike karịa.^[2]

Hụkwa

Propofol
Pentobarbital

Ntụaka

↑ (1967) "Effect of 5-imino-2,2,4,4-tetrakis (trifluoromethyl) imidazolidine (EXP 338) on spasticity: A quantitative evaluation". Clinical Pharmacology and Therapeutics 9 (4): 448–55. DOI:10.1002/cpt196894448. PMID 4871898.
↑ (April 1971) "The pharmacology and toxicology of midaflur". Toxicology and Applied Pharmacology 18 (4): 917–43. DOI:10.1016/0041-008x(71)90239-0. PMID 5570243.

[1] (1967) "Effect of 5-imino-2,2,4,4-tetrakis (trifluoromethyl) imidazolidine (EXP 338) on spasticity: A quantitative evaluation". Clinical Pharmacology and Therapeutics 9 (4): 448–55. DOI:10.1002/cpt196894448. PMID 4871898.

[2] (April 1971) "The pharmacology and toxicology of midaflur". Toxicology and Applied Pharmacology 18 (4): 917–43. DOI:10.1016/0041-008x(71)90239-0. PMID 5570243.

[1]

[2]